Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Life Insurance

AXA Equitable Gets Closer to IPO

X
Your article was successfully shared with the contacts you provided.

Article Archive: The Great Life & Annuity Realignment

AXA Equitable Holdings Inc. is taking a major step toward preparing itself to become more independent from its Paris-based parent, AXA S.A.

AXA Equitable, which has been based in New York for more than 150 years, has announced the price of $3.8 billion in senior notes.

The company hopes to use the cash it gets from the note purchasers to pay off loans from its parent; pay off commercial paper debts associated with a subsidiary, AXA Financial Inc.;  and buy units of limited partnerships in AllianceBernstein L.P. from AXA S.A.

AXA S.A. is getting ready to sell some of its AXA Equitable stock to the public through an initial public offering, or IPO.

The financial arrangements AXA Equitable is planning now, ”when effected, will complete the company’s pre-IPO reorganization transactions,” AXA Equitable said Wednesday, in an announcement of the note pricing decisions.

The company plans to issue:

  • $800 million in senior notes that will pay a rate of 3.9% and come due in 2023.
  • $1.5 billion in notes that will pay 4.35% and come due in 2028.
  • $1.5 billion in notes that will pay 5% and come due in 2048.

When AXA Equitable designates the notes as “senior,” that means the holders of the notes would come before some other note holders if AXA Equitable were unable to meet all of its obligations to its lenders.

AXA Equitable said it will issue the notes through a private offering.

— Read 3 AXA Equitable IPO Answers on ThinkAdvisor.

— Connect with ThinkAdvisor Life/Health on Facebook and Twitter.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.